| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2015-8518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-28123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14144 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc8d7cbf9e47662ade092d1afb198c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63d982c543fe06092cf2cd015b49c1f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa8c85e6dc3160b6d0e5ef5f01197f61 |
| publicationDate |
2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019178288-A2 |
| titleOfInvention |
Virus-like nanocapsid for oral delivery of insulin |
| abstract |
Hepatitis E virus (HEV)-based virus like particles (VLP) made with a modified capsid protein containing at least a portion of open reading frame 2 (ORF2) protein and encapsulated insulin protein or insulin encoding nucleic acid are provided. Also provided are methods of targeted delivery of insulin using the HEV VLP. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019236870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11466055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3802570-A4 |
| priorityDate |
2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |